BeStock  
Markets › Compare › LBLCF vs EW

LBLCF vs EW

Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.

vsvs
LBLCF · LOBLAWS COMPANIES LIMITED$43.47 ▼ 0.66%
EW · Edwards Lifesciences$87.23 ▲ 2.44%

One year, rebased to 100

Each line starts at 100 so growth is directly comparable

93102112122131Oct 7, '25Apr 7, '26Oct 2, '26
  • LBLCF +12.7%
  • EW +11.0%

Head to head

MetricLBLCFEW
Price$43.47$87.23
Change today▼ 0.66%▲ 2.44%
Market cap$50.23B$50.28B
Return, 3 months+0.2%-8.0%
Return, year to date-3.2%+2.3%
Return, 1 year+11.3%+13.9%
P/E (TTM)27.050.7
P/B6.54.7
P/E percentile vs own 5y–92nd
Dividend yield1.00%–
Revenue growth (YoY, latest qtr)–+13.6%
Net profit growth (YoY)–-27.2%
Gross margin–77.8%
Operating margin–28.1%
Net margin–15.4%
Return on equity–9.5%
Analyst target vs. price–+18.5%
Analyst buy share–82%
RSI (14)4249
30-day volatility18.1%23.9%
Max drawdown, 1 year-14.1%-13.2%
Trend readStrong downtrendLeaning bullish
Analyst consensus–Buy

Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.

What the numbers say

  • EW is the largest of the group by market value.
  • EW has returned the most over the past year.
  • LBLCF carries the lowest trailing P/E.
  • LBLCF has been the calmest stock over the last 30 days.

Go deeper

Scroll to Top